Iftekhar D. Kalsekar, Ph.D. - Publications

2004 West Virginia University, Morgantown, WV, United States 
Pharmacy, Public Health

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Chang TE, Jing Y, Yeung AS, Brenneman SK, Kalsekar ID, Hebden T, McQuade RD, Baer L, Kurlander JL, Watkins AK, Siebenaler JA, Fava M. Depression monitoring and patient behavior in the Clinical Outcomes in MEasurement-Based Treatment (COMET) trial. Psychiatric Services (Washington, D.C.). 65: 1058-61. PMID 25082605 DOI: 10.1176/appi.ps.201300326  0.56
2007 Hassan M, Madhavan SS, Kalsekar ID, Makela EH, Rajagopalan K, Islam S, Kavookjian J, Miller LA. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. The Annals of Pharmacotherapy. 41: 1812-8. PMID 17925501 DOI: 10.1345/aph.1K205  0.56
2006 Kalsekar ID, Madhavan SS, Amonkar MM, Douglas SM, Makela E, Elswick BL, Scott V. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Clinical Therapeutics. 28: 306-18. PMID 16678652 DOI: 10.1016/j.clinthera.2006.02.005  0.56
2006 Kalsekar ID, Madhavan SM, Amonkar MM, Scott V, Douglas SM, Makela E. The effect of depression on health care utilization and costs in patients with type 2 diabetes. Managed Care Interface. 19: 39-46. PMID 16583789  0.56
2006 Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BL. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. The Annals of Pharmacotherapy. 40: 605-11. PMID 16551768 DOI: 10.1345/aph.1G606  0.56
2003 Kalsekar ID, Makela EH, Moeller KE. Analysis of West Virginia medicaid claims data for the prevalence of medical conditions and use of drugs likely to cause QT prolongation in patients with schizophrenia. Current Therapeutic Research, Clinical and Experimental. 64: 538-50. PMID 24944403 DOI: 10.1016/j.curtheres.2003.08.007  0.56
2002 Amonkar MM, Kalsekar ID, Boyer JG, Monsanto HA, Mallet L. The economic burden of Barrett's esophagus in a Medicaid population Annals of Pharmacotherapy. 36: 605-611. PMID 11918506  0.56
Show low-probability matches.